Focus on specialty drugs reflects ‘cyclical nature’ of biopharma, industry veteran says

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2019 at 7:52 PM.

  1. #1 cafead, May 17, 2019 at 7:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Adam Schechter, an adviser to Merck's CEO, said at the Veeva Summit Tuesday that many primary care diseases - such as cardiovascular disease and Alzheimer's - still have significant unmet needs.

    article source
     
    Quote

Reply to Thread